Skip to content
Review

Autophagy -Regulated Myocardial Fibrosis: From Mechanistic Exploration to Therapeutic Prospects.

Aug 2026 · Canadian Journal of Physiology and Pharmacology · 0 citations
Medicine

TL;DR

Autophagy serves as a crucial modulator of myocardial fibrosis through multiple interconnected molecular pathways, underscoring the need for further research to translate these mechanisms into effective clinical interventions.

Abstract

Background

Cardiovascular diseases (CVDs) represent a leading cause of global mortality. Myocardial fibrosis (MF), a common pathological hallmark in CVDs, signifies disease progression to severe stages. Its pathogenesis is highly complex, with autophagy playing a pivotal regulatory role.

Methods

This narrative review synthesizes and critically evaluates the current literature to elucidate the interplay between MF and autophagy. The focus lies on systematically examining the molecular mechanisms and key signaling pathways involved in autophagy-mediated regulation of MF. Review Content: We systematically examine key molecular pathways and components through which autophagy regulates MF, including mitophagy, the NLRP3 inflammasome, FOXO signaling, the ULK1 complex, the mTOR pathway, and TGF-β signaling. These pathways collectively influence fibroblast activation, collagen metabolism, and overall cardiac extracellular matrix remodeling.

Conclusions

Autophagy serves as a crucial modulator of myocardial fibrosis through multiple interconnected molecular pathways. Targeting specific nodes within the autophagic process holds significant therapeutic promise for mitigating MF and slowing CVD progression. This review consolidates current understanding and highlights novel insights, underscoring the need for further research to translate these mechanisms into effective clinical interventions.

View source

Similar papers

Review Sep 2026

Recent Advances in Natural Product Interventions on Cardiovascular Disease: The Role of Programmed Cell Death.

Natural products targeting dysregulated PCD pathways may represent a promising multi-target therapeutic strategy for cardiovascular protection; however, current evidence is derived predominantly from preclinical studies, and further in-depth mechanistic investigations and high-quality clinical studies are warranted to...

Li-Ping Yang, Hui-Ping Wei, Zhao-Di Yang et al. · 0 citations
Review Open access Aug 2026

TREM2 signaling in cardiovascular disease: macrophage heterogeneity, timing, and therapeutic opportunity.

This review systematically delineates the spatiotemporal dynamics and functional duality of TREM2+ macrophages across major cardiovascular conditions, and further evaluates the current evidence and limitations of soluble TREM2 (sTREM2) as a candidate biomarker and critically appraises translational strategies targeting...

Ke Yang, Xue-Fang Ma, Bin-Yan Wang et al. · 1 citation
Review Open access Sep 2026

Novel applications of SIRT1 in Chronic Kidney Disease

Chronic kidney disease (CKD) has become a global public health issue, with progressive kidney fibrosis serving as a key pathological process leading to kidney failure, and current therapeutic approaches remain largely ineffective in reversing this progression. SIRT1, as an NAD⁺-dependent deacetylase, plays a central pr...

Yu-Cheng Han, Qian-Wei Wang, Xuan-Bing Pan et al. · 0 citations
Review Sep 2026

Advances in Calcium Transients and Autophagy.

This study summarizes the pathogenic roles of the calcium-autophagy regulatory axis in cardiovascular disorders, neurological diseases, malignant tumors, and renal diseases, and deeply analyzes the inherent limitations and translational bottlenecks of current broad-spectrum therapeutic strategies targeting general calc...

Jiang-Feng Xu, Xing-Le Tan, Yu-Ting Li et al. · 0 citations
Review Open access Aug 2026

The role of HIF-1α in myocardial ischemia protection mechanisms and multi-target rational regulation strategies for natural products

Current insights into the regulatory role of HIF-1α in myocardial ischaemic injury are summarized and the therapeutic potential of NPs in modulating this pathway is highlighted, providing a foundation for novel anti-ischaemic drug development.

Sisi He, Yuyao Wang, Qi Shi et al. · 0 citations
Review Open access Aug 2026

Significance of the PI3K/AKT pathway in coronary microvascular dysfunction and advances in natural compound therapeutic research 

Introduction: Coronary microvascular dysfunction (CMD) contributes to myocardial ischemia and adverse cardiovascular outcomes, but effective treatments remain limited. Objective: This review aims to clarify the role of the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway in CMD and assess the therapeutic p...

Yijia Du, Xujin Ning, Jingguo Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.